If you liked this article you might like

Trade-Ideas: Merrimack Pharmaceuticals (MACK) Is Today's Strong On High Relative Volume Stock
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Merrimack Pharmaceuticals (MACK) Weak On High Volume Today